Year: 2011

Luis Pérez-Jurado, ”losartan gives good results for treating heart problems in Williams-Beuren syndrome”

Losartan, a drug used against high blood pressure, is an effective treatment for cardiac complications of the cardiovascular phenotype of Williams-Beuren syndrome. This is the result of a recent clinical trial coordinated by the researcher Luis Pérez-Jurado, of the University Pompeu Fabra University and CIBER of Rare Diseases. Pérez-Jurado spoke about the study and the …

Luis Pérez-Jurado, ”losartan gives good results for treating heart problems in Williams-Beuren syndrome” Read More »

IDIBELL researcher Manel Esteller, elected Academician of the Spanish Royal Academy of Pharmacy

Manel Esteller, director of the Cancer Epigenetics and Biology program of IDIBELL, ICREA research professor and associate professor at the University of Barcelona, has been elected as a new Academician of the Spanish Royal Academy of Pharmacy on December 14th. The Royal Academy of Pharmacy, which dates back to 1589, is a public scientific society …

IDIBELL researcher Manel Esteller, elected Academician of the Spanish Royal Academy of Pharmacy Read More »

IDIBELL Administration begins the process for ISO 9001 certification

IDIBELL’s administrative area has begun process of implementation to be certified by ISO 9001 standard. The project is being coordinated by the Quality Direction and involves all the institution’s administrative departments: Purchasing Contract, Accounting, Human Resources, IT, Prevention, General Services and Maintenance and TTO. The certification obtaining is scheduled for December 2012. IDIBELL’s bet to …

IDIBELL Administration begins the process for ISO 9001 certification Read More »

Presented certificates of IDIBELL summer internships

On December 2nd was held the awarding of diplomas to the ten students who have completed the summer internship at IDIBELL. The event was chaired by the Director General of IDIBELL, Emilià Pola. Also attending the scientific director, Gabriel Capellà, the scientific deputy director, Marga Nadal and the researchers Isabel Fabregat, Cristina Muñoz-Pinedo, Merce Perez, …

Presented certificates of IDIBELL summer internships Read More »

Jordi Sunyer: “Our prenatal environment is fundamental in our mental development”

Air pollution is one of the most common environmental hazards that affect up to 100% of the population from birth to death. The co-director of CREAL (Centre for Research in Environmental Epidemiology), Jordi Sunyer, explained in the seminar series IDIBELL his research in this field. Several studies have shown that environmental exposures and nutrition during …

Jordi Sunyer: “Our prenatal environment is fundamental in our mental development” Read More »

IDIBELL is among the 120 top research centers in the world

The Scimago international ranking of Research Institutions places IDIBELL on 115th position among the 500 most highly-rated institutions in the world in all disciplines by its index and normalized impact with an excellence rate of 27.3. The report analyzes the scientific articles published by more than three thousand institutions in 104 different countries between 2005 …

IDIBELL is among the 120 top research centers in the world Read More »

Ferran Azorín: “Knowledge of basic mechanisms of epigenetics will allow us to develop new therapeutic strategies”

The laboratory of the Molecular Biology Institute of the CSIC in Barcelona led by Ferran Azorin, focuses its research on trying to understand the basic mechanisms that regulate genome function through epigenetics. The researcher has explained its latest advances in this field in the IDIBELL seminar series on November 25. One of the epigenetic factors …

Ferran Azorín: “Knowledge of basic mechanisms of epigenetics will allow us to develop new therapeutic strategies” Read More »

Jean-Ehrland Ricci: ”We investigate how targeting glycolysis may influence immune response anti-cancer”

The researcher at INSERM (French Institute for Health and Medical Research) Jean-Ehrland Ricci examines the correlation between glycolysis, cell death and immune response in tumor cells. He explained his latest developments in his research on IDIBELL seminar series November 18. Most cancer cells exhibit increased glycolysis for the generation of their energy supply (named the …

Jean-Ehrland Ricci: ”We investigate how targeting glycolysis may influence immune response anti-cancer” Read More »

Scroll to Top